FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Drug Evaluation and Research
  HHS Logo links to Department of Health and Human Services website

FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER

horizonal rule
CDER Home About CDER Drug Information Regulatory Guidance CDER Calendar Specific Audiences CDER Archives
 
Powered by Google
 

First-Time Generics - March 2003

  Generic Drug Name Generic Manufacturer Brand Name Approval Date
1 NOREPINEPHRINE BITARTRATE INJECTION, USP 1 MG (BASE)/ML, PACKAGED IN 4 MG (BASE)/4 ML SINGLE-DOSE VIALS GENSIA SICOR PHARMACEUTICALS, INC. LEVOPHED INJECTION 3/3/2003 
2 AMPHETAMINE AND DEXTROAMPHETAMINE (MIXED SALTS) TABLETS 7.5 MG (TOTAL), 12.5 MG (TOTAL), AND 15 MG (TOTAL) BARR PHARMACEUTICALS, INC. ADDERALL TABLETS 3/19/2003 
3 CARBINOXAMINE MALEATE TABLETS, USP 4 MG MIKART, INC. CLISTIN TABLETS 3/19/2003 
4 CEFADROXIL FOR ORAL SUSPENSION, USP 125 MG/5 ML, 250 MG/5 ML, AND 500 MG/5 ML RANBAXY LABORATORIES LIMITED DURACEF FOR ORAL SUSPENSION 3/26/2003 
5 ACETAMINOPHEN AND CODEINE PHOSPHATE TABLETS, USP 500 MG/30 MG ANDRX PHARMACEUTICALS, L.L.C. ACETAMINOPHEN AND CODEINE PHOSPHATE TABLETS U 3/27/2003 
6 ACETAMINOPHEN AND CODEINE PHOSPHATE TABLETS, USP 500 MG/60 MG ANDRX PHARMACEUTICALS L.LC. ACETAMINOPHEN AND CODEINE PHOSPHATE TABLETS 3/28/2003 
7 PROMETHAZINE HYDROCHLORIDE SUPPOSITORIES, USP 12.5 MG (NEW STRENGTH) G & W LABORATORIES, INC. PHENERGAN SUPPOSITORIES 3/31/2003 
8 IPRATROPIUM BROMIDE NASAL SOLUTION (NASAL SPRAY) 0.03% (0.021 MG/SPRAY) DEY, L.P. ATROVENT NASAL SPRAY 3/31/2003 
9 IPRATROPIUM BROMIDE NASAL SOLUTION, (NASAL SPRAY) 0.06% (0.042 MG/SPRAY) DEY, L.P. ATROVENT NASAL SPRAY 3/31/2003 

 

to top arrow Back to Top     back arrow Back to Approvals

Date created: April 10, 2003

horizonal rule